Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion

27 February 2023, Zwingenberg (Germany) - BRAIN Biotech AG, a leading provider of integrated solutions for the biologization of industry, has today at its fourth Capital Markets Day (CMD) informed investors about its future strategy. The company sees significant opportunities in the biotransformation of the economy and is well positioned to benefit from strong global sustainability initiatives in the areas of health, nutrition and the environment.